Ascenda BioSciences

Alpharetta, United States Founded: 2012 • Age: 14 yrs
Diagnostic services for microbe detection are provided using PCR-DNA technology.

About Ascenda BioSciences

Ascenda BioSciences is a company based in Alpharetta (United States) founded in 2012.. Ascenda BioSciences has completed 1 acquisition, including Provista Diagnostics. Ascenda BioSciences operates in a competitive market with competitors including InDex Pharmaceuticals, Genedrive, SensID, Genturadx and Qantgene, among others.

  • Headquarter Alpharetta, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by

    (Jul 11, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ascenda BioSciences

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Ascenda BioSciences

Ascenda BioSciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Provista Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Blood-based diagnostic tests for early women's cancer detection are developed.
2007
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Ascenda BioSciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ascenda Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ascenda BioSciences

Ascenda BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InDex Pharmaceuticals, Genedrive, SensID, Genturadx and Qantgene, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
domain founded_year HQ Location
Provider of point of care molecular diagnostics platform for genotyping and sequence analysis
domain founded_year HQ Location
Reference materials for DNA diagnostic applications are developed.
domain founded_year HQ Location
Molecular diagnostic platforms for clinical PCR analysis are developed.
domain founded_year HQ Location
Cancer screening blood tests are offered for early disease detection.
domain founded_year HQ Location
Tumor genetic testing reagents and instruments are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ascenda Biosciences

Frequently Asked Questions about Ascenda BioSciences

When was Ascenda BioSciences founded?

Ascenda BioSciences was founded in 2012.

Where is Ascenda BioSciences located?

Ascenda BioSciences is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.

Who is the current CEO of Ascenda BioSciences?

Uriel Kusiatin is the current CEO of Ascenda BioSciences.

What does Ascenda BioSciences do?

Ascenda BioSciences was established in 2012 in Alpharetta, United States, within the biotechnology sector. Diagnostic testing services focused on microbe detection are offered to support medical diagnoses. PCR-DNA-based technology is employed to identify pathogens associated with conditions including Irritable Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), and Ulcerative Colitis (UC). Operations center on laboratory-based analysis for healthcare providers.

Who are the top competitors of Ascenda BioSciences?

Ascenda BioSciences's top competitors include C3J Therapeutics, InDex Pharmaceuticals and Bigtec Labs.

How many acquisitions has Ascenda BioSciences made?

Ascenda BioSciences has made 1 acquisition, including Provista Diagnostics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available